Delivery Order SPE2DR25D2014-SPE2DR26FZ69N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,002.72 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,798.03 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive, non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes a firm fixed price structure, reflecting a straightforward pharmaceutical procurement...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Fosfomycin 3 GM sachets under a firm fixed price contract with a ceiling value of $1,042.36. This delivery order, which is set to be completed by July 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.26 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 7, 2025, just one day after the award date of August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.50 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilized firm fixed pricing under a non-set-aside, competitive procurement process. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $21,445.91 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, with performance in Conshohocken, Pennsylvania and completion targeted for September 15, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed on September 12, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,706.63 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract is firm fixed price with a completion date of September 16, 2025, and represents a non-competitive set-aside award. Performance of this delivery order will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,643.52 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive award, issued on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,287.23 firm fixed price delivery order is for the provision of 4,564,085,519 units of the antibiotic medication Fosfomycin 3 GM Sachets. The award is associated with a larger indefinite delivery contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fosfomycin 3 GM sachets, a pharmaceutical product, with a ceiling value of $1,473.46 and a completion date of July 2, 2025. The contract is not designated as a set-aside and is therefore open to competition. Amerisourcebergen Drug Corp is the prime contractor,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ69NDelivery Order
The Defense Logistics Agency awarded a $3,719.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fosfomycin 3 GM Sachets, with an ultimate completion date of November 14, 2025. This non-set-aside competitive award was issued on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fosfomycin is a broad-spectrum antibiotic commonly used to treat urinary tract infections and other bacterial infections within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with DLA and supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/13/25 |